The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors
Open accessAbstract
Objectives Widespread implementation of HRQOL measurement in prostate cancer practice and research requires concise instruments. Having 50 questions, the full-length Expanded Prostate cancer Index Composite (EPIC) is cumbersome to administer outside of studies focusing exclusively on HRQOL. To facilitate HRQOL measurement in a broad range of prostate cancer research and practice settings, we developed and validated an abbreviated version of EPIC. Methods 50 questions that comprise the full-length EPIC-50 were evaluated to identify items suitable for elimination while retaining ability to measure the 5 prostate cancer-specific HRQOL domains of EPIC-50. The resulting abbreviated version (EPIC-26) was validated using question responses from 252 subjects who had brachytherapy, external radiotherapy or prostatectomy for prostate cancer. EPIC-26 internal consistency was measured by Cronbach's alpha coefficient and reliability by test-retest correlation. Results Based on high item-scale correlations, clinically relevant content, and preservation of domain psychometrics, 26 items were retained in EPIC-26 from 50 questions in the full length EPIC-50. High correlation was observed between EPIC-50 and EPIC-26 versions of urinary incontinence, urinary irritation/obstruction, bowel, sexual and vitality/hormonal domain scores (all r ≥0.96). Correlations between different domains were low, confirming that EPIC-26 retains the ability to discern 5 distinct HRQOL domains. Internal consistency and test-retest reliability for EPIC-26 (Cronbach's alpha ≥0.70 and r ≥ 0.69, respectively for all 5 HRQOL domains) support its validity. Conclusions EPIC-26 is a brief, valid and reliable subjective measure of health quality among prostate cancer patients and suitable for measuring HRQOL among patients undergoing treatment for early stage prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 1×
“Incontinence subscale (4) Leaking >1 time per day* 1 1 0.”
BackgroundWei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000) · Urology · doi:10.1016/s0090-4295(00)00858-x · Cited by 1,520
Self-citationQuality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997) · Urology · doi:10.1016/s0090-4295(97)00459-7 · Cited by 696
Does “normal” aging imply urinary, bowel, and erectile dysfunction? A general population survey
Korfage, I. J., Roobol, M., de Koning, H. J., Kirkels, W. J., Schröder, F. H., & Essink-Bot, M.-L. (2008) · Urology · doi:10.1016/j.urology.2008.01.058 · Cited by 45
Cited by
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
Prediction of Erectile Function Following Treatment for Prostate Cancer
Alemozaffar, M., Regan, M. M., Cooperberg, M. R., Wei, J. T., Michalski, J. M., Sandler, H. M., Hembroff, L., Sadetsky, N., Saigal, C. S., Litwin, M. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1333 · Cited by 323
Self-citationHoffman, K. E., Penson, D. F., Zhao, Z., Huang, L.-C., Conwill, R., Laviana, A. A., Joyce, D. D., Luckenbaugh, A. N., Goodman, M., Hamilton, A. S., et al. (2020) · JAMA · doi:10.1001/jama.2019.20675 · Cited by 298
A systematic review of sexual distress measures
Santos-Iglesias, P., Mohamed, B., & Walker, L. M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.02.020 · Cited by 51
Pham, Q., Cafazzo, J. A., & Feifer, A. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8051 · Cited by 22
Metadata
- Authors
- Szymanski, K. M., Wei, J. T., Dunn, R. L., & Sanda, M. G.
- Venue
- Urology
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 76
- Issue
- 5
- Pages
- 1245-1250
- ISSN
- 0090-4295 (ISSN-L)
- OpenAlex
- W2035429331
- Cited by
- 456
- References
- 6
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors. https://app.cochat.ai/papers/10.1016/j.urology.2010.01.027
- The paper
- Szymanski, K. M., Wei, J. T., Dunn, R. L., & Sanda, M. G. (2010). Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors. Urology. https://doi.org/10.1016/j.urology.2010.01.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.